Daclatasvir Dihydrochloride
Daclatasvir Dihydrochloride is a premium clinical composition utilized extensively under specialized clinical prescriptions.
Formulations based on "Daclatasvir Dihydrochloride" (9)
Qurdac
Daclatasvir
It is a daclatasvir tablet. It is manufactured by Strides Pharma.
Hepcinat Plus
Sofosbuvir / Daclatasvir
It is daclatasvir and sofosbuvir tablet. It is manufactured by Natco Pharma.
Sofokast Plus
Sofosbuvir / Daclatasvir
Sofokast Plus is a combination of 2 direct acting antivirals, effectively used against Hepatitis C virus.
Dacikast
Daclatasvir
It is a hepatitis C medicine, often used in combination with other drugs for HCV infections.
MyHep DVIR
Sofosbuvir / Daclatasvir
Hepcdac
Daclatasvir
Hepcdac 60 mg (Daclatasvir) is an anti-viral agent indicated for patients with different variants of hepatitis C viral (HCV) infection. Hepatitis C is caused by a single-stranded (ss) RNA virus whi...
DaciHep 60 mg (Daclatasvir)
Daclatasvir
Hepatitis C viral (HCV) infection is a liver disease caused by single-stranded (ss) RNA viruses categorized into 9 distinct genotypes. DaciHep 60 mg (Daclatasvir) with its potent inhibitory action ...
Daclahep
Daclatasvir
Daclahep 60 mg (Daclatasvir) is an anti-viral agent indicated for patients with different variants of hepatitis C viral (HCV) infection. Hepatitis C is caused by a single-stranded (ss) RNA virus wh...
Mydekla 60
Daclatasvir
MyDekla 60 mg (Daclatasvir Dihydrochloride) is a direct-acting antiviral (DAA) inhibitor drug specified for patients with chronic Hepatitis C viral (HCV) infection with genotype 1 or 3. After enter...